Medtronic Plc

Medtronic Plc

Medtronic Plc

Overview
Date Founded

1949

Headquarters

Lower Hatch Street, 20 On Hatch, Dublin, 2, IRL

Type of Company

Public

Employees (Worldwide)

90K

Industries

Medical Products & Equipment
Hospitals & Patient Services

Company Description

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Contact Data
Trying to get in touch with decision makers at Medtronic Plc? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer

Chief Executive Officer

Executive Vice President & Chief Financial Officer

Senior Vice President, General Counsel & Corporate Secretary of the Company & of Medtronic, Inc

Senior Vice President & Chief Human Resources Officer

President, Asia Pacific Region

President-Europe, Middle East & Africa Region

Principal Accounting Officer, Executive Vice President & Chief Financial Officer

Director of Public Relations

Communications Director

Board of Directors

Chief Executive Officer at Medtronic Plc

Future Chief Executive Officer at Medtronic Plc (Effective 04/2020)

President at The Brigham & Women's Hospital, Inc.

Former Chief Executive Officer at Pentair Plc

President & Chief Executive Officer at Textron, Inc.

Former Governor of Utah

Former Chairman & Chief Executive Officer at Eaton Corp. Plc

President & Chief Executive Officer at Amtrak

Former Chief Executive Officer at General Mills, Inc.

Director at Lucille Packard Children's Hospital

Paths to Medtronic Plc
Potential Connections via
Relationship Science
You
Medtronic Plc
Owners & Shareholders
Details Hidden

Wellington Management's investment services rely on their extensive independent research and include portfolio management styles and approaches in equities, fixed income securities, currencies and commodities, as well as asset allocation across these categories. The firm has a number of different disciplines when approaching research and these include asset allocation analysts, currency analysts, data scientists, factor analysts, fixed income credit analysts, fixed income market analysts, global industry analysts and research associates, macroanalysts, quantitative analysts and technical analysts. Wellington Management's portfolio management teams often include dedicated analysts who evaluate securities and other instruments for suitability based on the team's investment approach. The firm supplements their internal research with external research from sources such as broker/dealers and third-party research firms. These sources typically provide data, research and analysis and may serve as a gauge of market consensus.

Details Hidden

MFS Investment Management utilizes various investment techniques to implement its investment strategies, including, but not limited to, long and short-term purchases, short sales, margin transactions, options, and exchange-traded and over-the-counter derivatives or other methods to seek to achieve performance. They employ a variety of methods to evaluate securities, including fundamental and quantitative analysis. MFS Investment Management offers fundamental, active and research-driven equity strategies that strive for less volatility relative to benchmarks and greater value through changing markets. Fixed income strategy offers total return focused and credit oriented approach. Multi-Asset strategy is goal-oriented, diversified and disciplined investment approach that combines broad diversification across multiple asset classes, active asset allocation, and bottom-up security selection. MFS' retirement solutions are designed with a goal of maximizing growth and supporting income over a lifetime by focusing on long-term returns. MFS Blended Research is an approach to active equity management that combines the firm's fundamental research expertise with highly systematic quantitative research.

Details Hidden

Lazard Asset Management is known for its global perspective on investing and years of experience with global, regional and domestic portfolios. With more than 280 investment personnel worldwide, we offer investors of all types an array of equity, fixed income, and alternative investment solutions from our network of local offices in ten different countries. Our team-based approach to portfolio management helps us to deliver robust and consistent performance over time, and strong client relationships allow us to understand how to employ our capabilities to our clients' advantage. With over $146.0 billion in assets under management, we have offices located throughout the world in Bahrain, Boston, Chicago, Frankfurt, Hong Kong, London, Milan, Montreal, New York, San Francisco, Seoul, Sydney, Tokyo, Toronto, and Zurich. Lazard Asset Management’s business is a diversified, global investment platform that focuses on managing assets for our clients. As a result, throughout all market environments, we maintain a disciplined approach to investing with a research-driven investment process focusing on financial productivity and valuation. We believe there are substantial opportunities for value driven investors and continue to seek out and invest in companies with healthy balance sheets and sustainability of returns

Recent Transactions
Details Hidden

Medtronic Plc purchases Titan Spine, Inc. from Southlake Equity Group LLC

Details Hidden

Medtronic Plc purchases EPIX Therapeutics, Inc. from New Enterprise Associates, Stage Capital Ventures, Life Science Angels, Questa Capital Management LLC

Details Hidden

Medtronic Plc purchases Mazor Robotics Ltd.

Transaction Advisors
Legal Advisor

Advised onMedtronic Plc purchases CardioInsight Technologies, Inc. from Draper Triangle Ventures, Case Technology Ventures, JumpStart Ventures /Ohio

Legal Advisor

Advised onMedtronic Plc purchases Mazor Robotics Ltd.

Investment Advisor

Advised onMedtronic Plc purchases HeartWare International, Inc.

Legal Advisor

Advised onMedtronic Plc purchases HeartWare International, Inc.

Legal Advisor

Advised onMedtronic Plc purchases HeartWare International, Inc.

Legal Advisor

Advised onCardinal Health, Inc. purchases Medtronic Plc /Medical Supplies Bus from Medtronic Plc

Advisors & Consultants
Advisor

President & Managing Director at Morgan Stanley Investment Management, Inc.

Legal Advisor

Partner at Gibson, Dunn & Crutcher LLP

Advisor

Executive Vice President & President at Medtronic, Inc.

Clients

CVS Health Corp. engages in the provision of health care services. It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, Health Care Benefits and Corporate. The Pharmacy Services segment offers pharmacy benefit management solutions. The Retail or Long Term Care segment includes selling of prescription drugs and assortment of general merchandise. The Health Care Benefits segment offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, medical management capabilities. The Corporate segment involves in providing management and administrative services. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Founded in Richmond, Virginia, in 1882, Owens & Minor is the nation’s leading distributor of medical and surgical supplies to the acute-care market and a leading provider of healthcare supply chain management solutions. For the first 110 years, our company provided pharmaceutical, and medical and surgical supplies to drugstores and hospitals throughout selected areas of the United States. In 1992, we made a decision to sell our wholesale drug business and focus entirely on the medical/surgical marketplace. This wise decision has paid huge dividends. Today, our 5,100 teammates in 55 distribution centers and our home office serve 4,500 hospitals, integrated healthcare systems, alternate care locations, and the federal government with a comprehensive offering of medical and surgical products. The majority of our sales are consumable goods, such as disposable gloves, dressings, endoscopic products, needles and syringes, sterile procedure trays, surgical products and gowns, and urological and wound-closure products. We have established a great reputation for providing superior, world-class service and continually strive to exceed our customers’ expectations. We understand that if we take great care of our customers, they will take great care of us. Owens & Minor’s common shares are traded on the New York Stock Exchange under the symbol OMI. Our goal is to deliver long-term value to our shareholders and we have paid dividends consistently since 1930. Delivering the difference is our mantra, and we strive every day to live up to that.

Key Stats and Financials As of 2019
Market Capitalization
$142B
Total Enterprise Value
$134B
Earnings Per Share
$3.41
Revenue
$30.6B
Net Profit
$4.63B
EBITDA
$9.76B
EBITDAMargin
31.93%
Total Debt
$25.3B
Total Equity
$50.2B
Enterprise Value Sales
4.39x
Enterprise Value EBITDAOperating
13.75x
TEVNet Income
28.97x
Debt TEV
0.19x
Three Year Compounded Annual Growth Rate Of Revenue
1.95%
Five Year Compounded Annual Growth Rate Of Revenue
12.44%
Non-Profit Donations & Grants
$5,000 +
2017
Non-Profit Donations & Grants Received
$6.4M
2012
Investments
Details Hidden

Nanos Medical Shanghai Co. Ltd. is a Chinese company located in Shanghai. The firm develops, manufactures and markets disposable medical devices. It was founded in 2015 by Teng Cui.

Details Hidden

Shanghai Yosemite Clinic Co. Ltd. is a company headquartered in Shanghai, China, that operates medical and surgical hospital. It was founded in 2016.

Details Hidden

Semma Therapeutics, Inc. develops transformative therapies for patients who currently depend on insulin injections. It focuses on combining proprietary cells with a state-of-the-art device to provide a true replacement for the missing beta cells in a diabetic patient without immunosuppression. The company was founded by Robert A. Millman, Walter A. Blättler, Felicia Pagliuca, Jeff Imbaro and Douglas A. Melton in 2015 and is headquartered in Cambridge, MA.

Investors
Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Life Peer at United Kingdom House of Lords

Details Hidden

Investor at Nfocus Neuromedical, Inc.

Suppliers
Anika Therapeutics, Inc. Industrial Machinery & Manufacturing | Bedford, MA

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. Its products are based on hyaluronic acid, a natural chemical occurring, biocompatible polymer found throughout the body. It offers therapeutic products which include orthobiologics, dermal, ophthalmic, surgical, ophthalmic and veterinary. The company was founded in 1992 and is headquartered in Bedford, MA.

ANSYS, Inc. IT Consulting & Services | Canonsburg, PA

Founded in 1970, ANSYS employs more than 2,100 professionals, and many of them are engineers expert in fields such as finite element analysis, computational fluid dynamics, electronics and electromagnetics, and design optimization. Our staff includes more master’s and Ph.D.-level engineers than any other simulation provider. ANSYS is passionate about pushing the limits of world-class technology, all so our customers can turn their design concepts into successful, innovative products. The company has been recognized as one of the world's most innovative and fastest -growing companies by prestigious organizations including BusinessWeek and FORTUNE magazines. Over the years, our steady growth and financial strength reflect our commitment to innovation and R&D. We reinvest 15 percent of our revenues each year into research to continually refine our software. We are listed on the NASDAQ stock exchange.

OSI Systems, Inc. Computer Hardware | Hawthorne, California

OSI Systems has been committed for over thirty-five years to both comprehensive research into meaningful issues and high-technology solutions to what will make the world safer and healthier. Rapiscan Systems, Spacelabs Healthcare and OSI Optoelectronics have decades of experience and leadership in their markets. Most importantly, their reputation for service is a cornerstone to their longevity and positions of trust and partnership.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Medtronic Plc. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Medtronic Plc's profile does not indicate a business or promotional relationship of any kind between RelSci and Medtronic Plc.